Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy

Chia-Jen Shih; Hung-Ta Chen; Shu-Chen Kuo; Szu-Yuan Li; Pi-Hsiang Lai; Shu-Chen Chen; Shuo-Ming Ou; Yung-Tai Chen

doi:10.1503/cmaj.150771

Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy

Canadian Medical Association Journal ◽

10.1503/cmaj.150771 ◽

2016 ◽

Vol 188 (8) ◽

pp. E148-E157 ◽

Cited By ~ 11

Author(s):

Chia-Jen Shih ◽

Hung-Ta Chen ◽

Shu-Chen Kuo ◽

Szu-Yuan Li ◽

Pi-Hsiang Lai ◽

...

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Effects of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and their combination on microalbuminuria in normotensive patients with type 2 diabetes

Advances in Therapy ◽

10.1007/bf02850049 ◽

2006 ◽

Vol 23 (4) ◽

pp. 615-622 ◽

Cited By ~ 11

Author(s):

Aysegul Atmaca ◽

Olcay Gedik

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Summary of AHRQ's Comparative Effectiveness Review of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease

Journal of Managed Care Pharmacy ◽

10.18553/jmcp.2011.17.s5.1 ◽

2011 ◽

Vol 17 (5 Supp A) ◽

pp. 1-15

Author(s):

Michael White ◽

Laurence Greene

Keyword(s):

Heart Disease ◽

Angiotensin Ii ◽

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Standard Medical Therapy ◽

Receptor Blockers

Download Full-text

Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus

Medicine ◽

10.1097/md.0000000000010256 ◽

2018 ◽

Vol 97 (15) ◽

pp. e0256 ◽

Cited By ~ 4

Author(s):

Xiaodan lv ◽

Yingshi Zhang ◽

Yixuan Niu ◽

Qi Song ◽

Qingchun Zhao

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Hypertensive Patients ◽

Receptor Blockers

Download Full-text

The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes

Journal of Clinical Hypertension ◽

10.1111/jch.12647 ◽

2015 ◽

Vol 18 (3) ◽

pp. 200-206 ◽

Cited By ~ 2

Author(s):

Raj Padwal ◽

Mu Lin ◽

Dean T. Eurich

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Patients With Diabetes ◽

Receptor Blockers

Download Full-text

Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension

Annals of Internal Medicine ◽

10.7326/0003-4819-148-1-200801010-00189 ◽

2008 ◽

Vol 148 (1) ◽

pp. 16 ◽

Cited By ~ 194

Author(s):

David B. Matchar ◽

Douglas C. McCrory ◽

Lori A. Orlando ◽

Manesh R. Patel ◽

Uptal D. Patel ◽

...

Keyword(s):

Systematic Review ◽

Essential Hypertension ◽

Angiotensin Ii ◽

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Terms of Major Cardiovascular Disease Outcomes in Elderly Patients

Medicine ◽

10.1097/md.0000000000001751 ◽

2015 ◽

Vol 94 (43) ◽

pp. e1751 ◽

Cited By ~ 9

Author(s):

Shu-Chen Chien ◽

Shuo-Ming Ou ◽

Chia-Jen Shih ◽

Pei-Wen Chao ◽

Szu-Yuan Li ◽

...

Keyword(s):

Cardiovascular Disease ◽

Angiotensin Ii ◽

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Disease Outcomes ◽

Receptor Blockers

Download Full-text

Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers for Prevention and Treatment of Nephropathy Associated with Type 2 Diabetes Mellitus

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.2005.25.11.1602 ◽

2005 ◽

Vol 25 (11) ◽

pp. 1602-1620 ◽

Cited By ~ 13

Author(s):

David B. Hughes ◽

Mark L. Britton

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Prevention And Treatment ◽

Receptor Blockers

Download Full-text

Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Effectively and Directly Potentiate Superoxide Scavenging by Polymorphonuclear Leukocytes from Patients with Type 2 Diabetes Mellitus

The American Journal of the Medical Sciences ◽

10.1097/00000441-200505000-00002 ◽

2005 ◽

Vol 329 (5) ◽

pp. 222-227 ◽

Cited By ~ 9

Author(s):

Toshihiko Inukai ◽

Noboru Yoshida ◽

Sadao Wakabayashi ◽

Yoshihisa Inukai ◽

Rika Matsutomo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Polymorphonuclear Leukocytes ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Microalbuminuria in type 1 and type 2 diabetes mellitus: Evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy

Current Hypertension Reports ◽

10.1007/s11906-002-0069-3 ◽

2002 ◽

Vol 4 (5) ◽

pp. 387-393 ◽

Cited By ~ 37

Author(s):

Hans-Henrik Parving ◽

Peter Hovind

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

H-001 COMPARATIVE EFFECTIVENESS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR ANGIOTENSIN II–RECEPTOR BLOCKERS FOR DIABETIC NEPHROPATHY

Journal of Hypertension ◽

10.1097/01.hjh.0000408043.77355.5a ◽

2011 ◽

Vol 29 ◽

pp. e22

Author(s):

Hon-Yen Wu ◽

Yu-Kang Tu ◽

Kuo-Liong Chien

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text